Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro-Oesophageal Reflux Disease or Erosive Oesophagitis.
Saved in:
| Title: | Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro-Oesophageal Reflux Disease or Erosive Oesophagitis. |
|---|---|
| Authors: | Howden CW; University of Tennessee College of Medicine, Memphis, Tennessee, USA., Katz P; Division of Gastroenterology & Hepatology, Weill Cornell Medicine, New York, New York, USA., DeVault KR; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA., Metz DC; Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Tamene D; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USA., Smith N; Phathom Pharmaceuticals, Florham Park, New Jersey, USA., Hunt B; Phathom Pharmaceuticals, Florham Park, New Jersey, USA., Chang YM; Phathom Pharmaceuticals, Florham Park, New Jersey, USA., Spechler SJ; Division of Gastroenterology, Baylor University Medical Center and Baylor Scott & White Center for Esophageal Diseases, Dallas, Texas, USA. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2025 Mar; Vol. 61 (5), pp. 835-851. Date of Electronic Publication: 2024 Dec 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
